A Sri Lankan-born consultant physician is among the investigators involved in the Oxford Covid-19 Vaccine Group.
According to the Guardian, Sri Lankan-born consultant physician Dr. Maheshi Ramasamy is among the investigators involved in the creation of the Oxford Covid-19 Vaccine.
The University of Oxford’s latest trial results have suggested that the vaccine produces a strong immune response in older adults.
The University is expected to release data on the efficacy of its coronavirus vaccine candidate in the coming weeks.
Commenting on the vaccine, Sri Lankan-born consultant physician Dr. Ramasamy said older adults are a priority group for the Covid-19 vaccination because they are at increased risk of severe disease, but it is known that they tend to have poorer vaccine responses.
“We were pleased to see that our vaccine was not only well tolerated in older adults, but also stimulated similar immune responses to those seen in younger volunteers. The next step will be to see if this translates into protection from the disease itself,” Dr. Ramasamy added.
Meanwhile, researchers say their findings are promising as they show that older people are having a similar immune response to younger adults. (NewsWire)